Medpace
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $707,331 | $706,604 | $708,450 | $659,903 |
Gross Profit | 201,637 | 196,326 | 205,316 | 196,939 |
EBITDA | 133,830 | 154,497 | 163,964 | 149,885 |
EBIT | 140,736 | 147,591 | 156,833 | 142,836 |
Net Income | 121,362 | 123,870 | 135,133 | 111,135 |
Net Change In Cash | 707,331 | 706,604 | 708,450 | 659,903 |
Free Cash Flow | 138,100 | 144,974 | 188,116 | 262,316 |
Cash | 502,688 | 652,681 | 497,049 | 285,351 |
Basic Shares | 28,761 | 28,962 | 28,964 | 29,710 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,530,234 | $2,109,054 | $1,885,842 | $1,459,996 |
Gross Profit | 760,618 | 656,305 | 524,505 | 432,438 |
EBITDA | 570,501 | 505,173 | 362,498 | 308,106 |
EBIT | 542,377 | 475,922 | 336,170 | 285,765 |
Net Income | 451,123 | 404,386 | 282,810 | 245,368 |
Net Change In Cash | 2,530,234 | 2,109,054 | 1,885,842 | 1,459,996 |
Cost of Revenue | -426,467 | |||
Free Cash Flow | 681,867 | 572,267 | 396,726 | 351,171 |
Cash | 497,049 | 669,436 | 245,449 | 28,265 |
Basic Shares | 29,527 | 32,014 | 31,841 | 33,671 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $4.25 |
2026-03-31 | $4.28 |
2025-12-31 | $4.67 |
2025-09-30 | $3.86 |